Obstructive sleep apnoea among HIV patients

International Journal of STD and AIDS

Volumn 17, Issue 9, 2006, Pages 614-620

  Lo Re III, V ^a   Schutte Rodin, S ^a   Kostman, J R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

HIV; Obesity; Obstructive sleep apnoea; Sleep

Indexed keywords

ABACAVIR; AMPRENAVIR PHOSPHATE; ATAZANAVIR; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; RITONAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; FATIGUE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; MALE; MEDICAL RECORD; OBESITY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REVIEW; SLEEP APNEA SYNDROME; SNORING; SOMNOLENCE; WEIGHT GAIN;

ADULT; ANTHROPOMETRY; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; DEMOGRAPHY; FEMALE; HIV INFECTIONS; HUMANS; LIPODYSTROPHY; MALE; MIDDLE AGED; OBESITY; POLYSOMNOGRAPHY; POSITIVE-PRESSURE RESPIRATION; RETROSPECTIVE STUDIES; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; SLEEP STAGES; SNORING;

EID: 33748355643     PISSN: 09564624     EISSN: 09564624     Source Type: Journal    
DOI: 10.1258/095646206778113078     Document Type: Review

References (41)

1. Palella Jr FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60
2. Murphy EL, Collier AC, Kalish LA, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med 2001;135:17-26
3. Montessori V, Press N, Harris M, Akagi L, Montaner JS. Adverse effects of antiretroviral therapy for HIV infection. CMAJ 2004;170:229-38
4. Fellay J, Boubaker K, Ledergerber B, et al. Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet 2001;358:1322-7
5. Silva M, Skolnik PR, Gorbach SL, et al. The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS 1998;12:1645-51
6. Shikuma CM, Zackin R, Sattler F, et al. Changes in weight and lean body mass during highly active antiretroviral therapy. Clin Infect Dis 2004;39:1223-30
7. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F51-8
8. Carr A, Samaras K, Chisholm DJ, Cooper DA. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 1998;351:1881-3
9. Heath KV, Hogg RS, Chan KJ, et al. Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database. AIDS 2001;15:231-9
10. Carr A. HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management. AIDS 2003;17(Suppl 1):S141-8
11. Wagner GJ, Ferrando SJ, Rabkin JG. Psychological and physical health correlates of body cell mass depletion among HIV+ men. J Psychosom Res 2000;49:55-7
12. Dukers NH, Stolte IG, Albrecht N, Coutinho RA, de Wit JB. The impact of experiencing lipodystrophy on the sexual behaviour and well-being among HIV-infected homosexual men. AIDS 2001;15:812-13
13. Duran S, Saves M, Spire B, et al. Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy. AIDS 2001;15:2441-4
14. Ammassari A, Antinori A, Cozzi-Lepri A, et al. Relationship between HAART adherence and adipose tissue alterations. J Acquir Immune Defic Syndr 2002;31(Suppl 3):S140-4
15. Schulz R, Lohmeyer J, Seeger W. Obstructive sleep apnea due to HIV-associated lipodystrophy. Clin Infect Dis 2003;37:1398-9
16. Flemons WW, McNicholas WT. Clinical prediction of the sleep apnea syndrome. Sleep Med Rev 1997;1:19-32
17. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999;131:485-91
18. Flemons WW. Clinical practice. Obstructive sleep apnea. N Engl J Med 2002;347:498-504
19. Malhotra A, White DP. Obstructive sleep apnoea. Lancet 2002;360:237-45
20. Arens R, Marcus CL. Pathophysiology of upper airway obstruction: a developmental perspective. Sleep 2004;27:997-1019
21. Kushida CA, Efron B, Guilleminault C. A predictive morphometric model for the obstructive sleep apnea syndrome. Ann Intern Med 1997;127:581-7
22. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5
23. Practice parameters for the indications for polysomnography and related procedures. Polysomnography Task Force, American Sleep Disorders Association Standards of Practice Committee. Sleep 1997;20:406-22
24. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-89
25. American Sleep Disorders Association. EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;15:173-84
26. Bliwise DL. Normal aging. In: Kryger MH, Roth TD, Dement WC, eds. Principles and Practice of Sleep Medicine. 4th edn. Philadelphia, PA: Elsevier Saunders, 2005;24-38
27. Coleman RM. Periodic movements in sleep (Nocturnal Myoclonus) and restless legs syndrome. In: Guilleminault C, ed. Sleeping and Waking Disorders: Indications and Techniques. Menlo Park, CA: Addison-Wesley, 1982;265-95
28. Sullivan PS, Dworkin MS. Prevalence and correlates of fatigue among persons with HIV infection. J Pain Symptom Manage 2003;25:329-33
29. Aldrich MS, Rogers AE, Angell K. Excessive daytime sleepiness as a presenting manifestation of HIV infection. Sleep Res 1988;17:137
30. Rothenberg S, Zozula R, Funesti J, McAuliffe V. Sleep habits in HIV-seropositive individuals. Sleep Res 1990;19:342
31. Norman SE, Chediak AD, Kiel M, Cohn MA. Sleep disturbances in HIV-infected homosexual men. AIDS 1990;4:775-81
32. Norman SE, Chediak AD, Freeman C, et al. Sleep disturbances in men with asymptomatic human immunodeficiency (HIV) infection. Sleep 1992;15:150-5
33. Norman SE, Chediak AD. Longitudinal analysis of sleep disturbances in HIV-infected men. Sleep Res 1992;21:304
34. Epstein LJ, Strollo Jr PJ, Donegan RB, Delmar J, Hendrix C, Westbrook PR. Obstructive sleep apnea in patients with human immunodeficiency virus (HIV) disease. Sleep 1995;18:368-76
35. Kapuniai LE, Andrew DJ, Crowell DH, Pearce JW. Identifying sleep apnea from self-reports. Sleep 1988;11:430-6
36. Shinohara E, Kihara S, Yamashita S, et al. Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med 1997;241:11-18
37. Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A. Sleep apnea and sleep disruption in obese patients. Arch Intern Med 1994;154:1705-11
38. Richman RM, Elliott LM, Burns CM, Bearpark HM, Steinbeck KS, Caterson ID. The prevalence of obstructive sleep apnoea in an obese female population. Int J Obes Relat Metab Disord 1994;18:173-7
39. Resta O, Foschino-Barbaro MP, Legari G, et al. Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects. Int J Obes Relat Metab Disord 2001;25:669-75
40. Amorosa V, Synnestvedt M, Gross R, et al. A tale of two epidemics: the intersection between obesity and HIV infection in Philadelphia. J Acquir Immune Defic Syndr 2005;39:557-61
41. Diagnostic Classification Steering Committee of the American Sleep Disorders Association. The International Classification of Sleep Disorders: Diagnostic and Coding Manual. Rochester, Minnesota: Allen Press, 1990;65-8